Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.481 USD | -1.84% |
|
-16.78% | -15.61% |
Jun. 12 | XOMA Receives $8.1 Million Milestone Related to Sale of Priority Review Voucher | MT |
May. 30 | Day One Biopharmaceuticals Sells Priority Review Voucher for $108 Million | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.61% | 18.89M | |
+16.59% | 44.44B | |
+42.78% | 40.03B | |
-10.62% | 37.68B | |
+29.92% | 31.46B | |
-9.23% | 27.29B | |
+12.34% | 26.29B | |
+41.53% | 13.8B | |
+31.49% | 12.46B | |
-7.40% | 11.26B |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.
- HC Wainwright Lowers Price Target on Viracta Therapeutics to $10 From $33, Maintains Buy Rating